北京招聘

1.    Develop upstream processes for novel pipeline products and bispecific antibodies for research and development efforts

2.    Timely execution of all aspects of upstream mammalian cell culture operations

3.    Assess process optimization and validation based on design of experiment approaches of upstream processes for existing clinical products in preparation for Phase 3/commercial manufacturing

4.    Compile data to support/contribute to technical/development reports for technology transfer and regulatory submission

5.    Support technology transfer to contract manufacturing organizations

6.    Develop and perform analytical methods on cell culture media to support process development

7.    Support troubleshooting of technical issues and process improvement for higher efficiency

8.    Maintain scientific excellence and attention to detail

9.    Design and conduct experiments, collect and analyze data, write development reports

10.  Drive innovation through deep understanding of new technologies and methods in cell culture development

11.  Contribute to the IND filings

                        

Requirements:

1. BS/BA or MS in Chemical Engineering, Biotechnology, Cell Biology, Molecular Biology, Biochemistry or related field. Number of years of industry experience commensurate with job titles

2. Hands-on experience in mammalian cell culture techniques

3. Experience in cell culture process development for monoclonal antibodies, bispecific antibodies, Fc-fusions and other therapeutic proteins

4. Versatile in techniques in cell expansion and fed-batch/perfusion methodologies, assembly, sterilization, calibration, operation and control of small scale single use and glass bioreactors, analysis of cell growth, metabolic activity and productivity and methods for harvest clarification

5. Exceptionally strong communication and problem solving skills

6. Knowledge of Design of Experiment approaches for process optimization

7. Ability to work independently and multitask in a fast-paced environment

8. Responsible, organized and disciplined record keeping

9. Self-motivated, collaborative, and effective communication skill

  

  

和铂医药是一家专注于肿瘤免疫领域创新药物研究与开发的全球化运营生物医药公司。公司将运用其拥有的全部自主知识产权的全人源单抗的转基因鼠系列核心技术平台，建立下一代治疗性肿瘤抗体药物产品管线,并将围绕Harbour的两大平台拓展合作与授权业务。公司总部及研发基地位于中国上海，另外在美国马塞诸塞州剑桥设立商业运营中心，在荷兰鹿特丹设立抗体研发平台创新中心，在波士顿地区设立了创新中心包括实验室和研发团队，也将在江苏昆山设立研发基地。公司拥有资深管理团队以及丰富的药物研究与开发经验。和铂医药要为满足中国及全球病人的需求而不断努力，依托拥有自主知识产权的核心技术平台,创建一个在肿瘤治疗领域有科学与技术领导力的国际性生物医药公司。同时, 在药物研发领域建立以技术平台为基础的对外合作，整合新的技术，推动中国整个抗体研发产业的进步。

Company Overview
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology and autoimmunity/inflammation. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.
The company is building its proprietary pipeline internally, through collaborations with co-development partners, as well as through selective preclinical and clinical stage asset acquisitions. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary.
Harbour BioMed has headquarters and an R&D site in Shanghai, business operations in Cambridge, MA, and antibody platform development in Rotterdam, The Netherlands.
The company has an innovation center including research lab and a development team in Boston. Also, we are expanding to Kunshan site in Jiangsu for our R&D operation.